01477.HK
Ocumension Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 5.37
+1.23%Margins
Gross margin
45.5%
EBITDA margin
-17.4%
EBIT margin
-27.4%
Net margin
-25.4%
FCF margin
-24.4%
-10.3%
Return on equity
-9.1%
Return on assets
-10.3%
Return on invested capital
0.36x
Asset turnover
-HKD 122.7M
Cash from operations
HKD 0.38
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026